Skip to main content

Part of COSD user guide v10.2.8

Core – Molecular and biomarkers

Previous Chapter

Core - Cancer care plan

Current Chapter

Current chapter – Core – Molecular and biomarkers

View all

Next Chapter

Core - Clinical trials

Page contents

Introduction

The ambition was always to get all the molecular and biomarker outcome data direct from the reporting laboratories themselves; once that was achieved, data collected through COSD would cease.

Germline testing for cancer predisposition

It is important to note that this complete section has been removed on the advice of the COSD Governance Board, following a thorough 6-month clinical review.

All data items within this section have been retired from v10, as we now have more accurately collection direct from Genomic Laboratories.

Somatic testing for targeted therapy and personalised medicine

It is important to note that this complete section has been removed on the advice of the COSD Governance Board, following a thorough 6-month clinical review.

All data items within this section have been retired from v10, as we now have more accurately collection direct from Genomic Laboratories.

Last edited: 16 June 2023 3:05 pm

Previous Chapter

Core - Cancer care plan

Next Chapter

Core - Clinical trials
  1. COSD user guide v10.2.8
  2. Executive summary
  3. Collecting and submitting COSD data
  4. Clinical terminology integration within COSD
  5. How to record recurrence, progression, and transformations
  6. Key to data tables and ICD-10 codes
  7. Core - Linkage
  8. Core- Demographics
  9. Core – Referrals and first stage of patient pathway
  10. Core - Non primary cancer pathway – Referral
  11. Core - Imaging
  12. Core – Diagnostic procedures
  13. Core – Diagnosis
  14. Core – Person observation
  15. Core - Clinical Nurse Specialist + Risk Factor Assessment
  16. Core – Multidisciplinary Team Meetings (MDT)
  17. Core – Cancer Care Plan
  18. Core – Molecular and biomarkers
  19. Core – Clinical trials
  20. Core – Staging
  21. Core – Site specific staging
  22. Core – Treatment
  23. Core – Acute oncology
  24. Core – Laboratory results
  25. Site specific - Breast
  26. Site specific - Central Nervous System
  27. Site specific - Colorectal
  28. Site specific - Children Teenagers and Young Adults (CTYA)
  29. Site specific - Gynaecological
  30. Site specific - Haematological
  31. Site specific - Head and neck
  32. Site specific - Liver and cholangiocarcinoma
  33. Site specific - Lung
  34. Site specific - Sarcoma
  35. Site specific - Skin
  36. Site specific - Upper GI
  37. Site specific - Urological
  38. Appendix and downloads